Background:
The Covid-19 pandemic caused a negative impact on other infectious diseases control, prevention, and treatment. Consequently, low and middle-income countries suffer from other endemic diseases, such as tuberculosis. This study was designed to compare Covid-19 manifestations and outcomes between patients with previously treated tuberculosis and controls without this condition.
Methods:
We performed a matched case-control study drawn from the Brazilian Covid-19 Registry data, including in-hospital patients aged 18 and over with laboratory-confirmed Covid-19 from March 1, 2020 to March 31, 2022. Cases were patients with a past history of tuberculosis. Controls were Covid-19 patients without tuberculosis history. Patients were matched by hospital, sex, presence of HIV and number of comorbidities, with a 1:4 ratio.
Results:
From 13,636 patients with laboratory-confirmed diagnosis of Covid-19 enrolled in this study, 80 had a history of tuberculosis. Statistical differences in history of chronic pulmonary obstructive disease (15% vs 3.2%), psychiatric disease (10% vs 3.5%,), chronic kidney disease (11.2% vs 2.8%) and solid-organ transplantation; (5% vs 0.9%, p<0.05 for all) were higher in patients with a past history of tuberculosis. Prior use of inhalatory medications (5% vs 0.6%,), oral corticoids (8.8% vs 1.9%), immunosuppressants (8.8% vs 1.9%,) and the use of illicit drugs were more common in the case group (6.2% vs 0.3% p<0.05for all). There were no significant differences in in-hospital mortality, mechanical ventilation, need for dialysis and ICU admission.
Conclusions:
Patients with a history of tuberculosis infection presented a higher frequency of use of illicit drugs, chronic pulmonary obstructive disease, psychiatric disease, chronic kidney disease, solid-organ transplantation, prior use of inhalatory medications, oral corticoids, and immunosuppressants. The outcomes were similar between cases and controls.